» Articles » PMID: 3753802

Sequence and Expression of Human Estrogen Receptor Complementary DNA

Overview
Journal Science
Specialty Science
Date 1986 Mar 7
PMID 3753802
Citations 242
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanism by which the estrogen receptor and other steroid hormone receptors regulate gene expression in eukaryotic cells is not well understood. In this study, a complementary DNA clone containing the entire translated portion of the messenger RNA for the estrogen receptor from MCF-7 human breast cancer cells was sequenced and then expressed in Chinese hamster ovary (CHO-K1) cells to give a functional protein. An open reading frame of 1785 nucleotides in the complementary DNA corresponded to a polypeptide of 595 amino acids and a molecular weight of 66,200, which is in good agreement with published molecular weight values of 65,000 to 70,000 for the estrogen receptor. Homogenates of transformed Chinese hamster ovary cells containing a protein that bound [3H]estradiol and sedimented as a 4S complex in salt-containing sucrose gradients and as an 8 to 9S complex in the absence of salt. Interaction of this receptor-[3H]estradiol complex with a monoclonal antibody that is specific for primate ER confirms the identity of the expressed complementary DNA as human estrogen receptor. Amino acid sequence comparisons revealed significant regional homology among the human estrogen receptor, the human glucocorticoid receptor, and the putative v-erbA oncogene product. This suggests that steroid receptor genes and the avian erythroblastosis viral oncogene are derived from a common primordial gene. The homologous region, which is rich in cysteine, lysine, and arginine, may represent the DNA-binding domain of these proteins.

Citing Articles

Interaction between Estrogen Receptors and p53: A Broader Role for Tamoxifen?.

Das G, Oturkar C, Menon V Endocrinology. 2025; 166(3).

PMID: 39891710 PMC: 11837209. DOI: 10.1210/endocr/bqaf020.


Hormone Signaling in Breast Development and Cancer.

Agnoletto A, Brisken C Adv Exp Med Biol. 2025; 1464():279-307.

PMID: 39821031 DOI: 10.1007/978-3-031-70875-6_15.


The other side of the coin: protein deubiquitination by Ubiquitin-Specific Protease 1 in cancer progression and therapy.

Hu X, Wu Y, Yao M, Chen Z, Li Q Future Med Chem. 2025; 17(3):329-345.

PMID: 39819213 PMC: 11792837. DOI: 10.1080/17568919.2025.2453414.


Current Therapeutic Opportunities for Estrogen Receptor Mutant Breast Cancer.

Palaniappan M Biomedicines. 2025; 12(12.

PMID: 39767607 PMC: 11673253. DOI: 10.3390/biomedicines12122700.


Divergent mechanisms of steroid inhibition in the human ρ1 GABA receptor.

Fan C, Cowgill J, Howard R, Lindahl E Nat Commun. 2024; 15(1):7795.

PMID: 39242530 PMC: 11379708. DOI: 10.1038/s41467-024-51904-7.